Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15126 - 15150 of 15259 in total

P-Hydroxybenzaldehyde

Experimental

Acetylcysteine zidrimer

Investigational

3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione

Experimental

5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE

Experimental

4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one

Experimental

1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE

Experimental

NRP409

NRP409 is a triiodothyronine (T3) hormone, being investigated by New River Pharmaceuticals as a treatment for patients with primary hypothyroidism.
Investigational

Dapansutrile

Dapansutrile is under investigation in clinical trial NCT01768975 (Phase 2 Efficacy Trial of OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With OA of the Knee).
Investigational

S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate

Experimental

Cambinol

Cambinol is a beta-naphtol derivative that inhibits NAD-dependant deacetylases to reduce cell survival under stress. This activity is currently being investigated for its use as a cancer treatment.
Experimental

8-azaxanthine

Experimental

3,5-Diaminophthalhydrazide

Experimental

Nitrosoethane

Experimental

Napabucasin

Napabucasin has been investigated for the treatment of Colorectal Carcinoma.
Investigational

Methyl isocyanate

Methyl isocyanate has been investigated for the treatment of Nosocomial Pneumonia.
Investigational

Pridopidine

Pridopidine has been used in trials studying the treatment of Huntington's Disease.
Investigational

Oxomemazine

Experimental

(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE

Experimental

9-Deazahypoxanthine

Experimental

REN-850

REN-850 is an oral drug for multiple sclerosis which is in Phase I of clinical trials.
Investigational

2-Methyl-3-(2-Aminothiazolo)Propanal

Experimental

3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one

Experimental

AP5346

AP5346 is designed to target a diaminocyclohexane platinum (Pt) moiety to tumors through pH-sensitive linkage to a 25 kDa hydroxypropylmethacrylamide polymer. It is being pursued by Access Pharmaceuticals, Inc.
Investigational

Terevalefim

Terevalefim is under investigation in clinical trial NCT02474667 (Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney).
Investigational

6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione

Experimental
Displaying drugs 15126 - 15150 of 15259 in total